Lupus & antiphospholipid syndrome

Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort

Lupus Sci MedPublished Retrospective cohort study

Authors' conclusion

Our data showed that LAC+, RNP+, RP and a scleroderma pattern at NVC was indicative for patients with SLE-PAH.

Study context

Population
Patients with systemic lupus erythematosus (SLE) with and without pulmonary arterial hypertension (PAH)
Participants
20 vs 87
Exposure
SLE with PAH vs SLE without PAH
  • SLE-PAHn = 20
  • No-PAHn = 87reference
Outcome
Clinical features and nailfold capillary changes associated with PAH in SLE
Methodological detailsmulticentre, case-control comparison
  • Multicentre
  • Case-control comparison

Further findings

LA positivity

P = 0.042

Anti-RNP positivity

P = 0.035

Mucocutaneous involvement

P = 0.024

Central nervous system involvement

P = 0.046

RP

P < 0.001

Scleroderma pattern at NVC · NVC performed in nine patients with PAH and in controls

P < 0.001

Raynaud's phenomenon (RP) as predictor of PAH in SLE

OR (CI)
RP3.8 (0.9–14.8)

Anti-Sm, anti-Ro, anti-La, aCL and anti-beta2GPI antibodies

No differences were observed

Capillary density and giant capillaries at nailfold videocapillaroscopy (NVC)

SLE-PAH showed lower capillary density and higher frequency of giant capillaries

Sex, age and disease duration

All patients with SLE-PAH were women; age and disease duration not different from no-PAH

Original publication

Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort. Lupus Sci Med. Published 12 June 2025. doi:10.1136/lupus-2024-001471

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.